Schirizzi, A.; Arshadi, A.; Tolomeo, D.; Schirosi, L.; Valentini, A.M.; De Leonardis, G.; Refolo, M.G.; Donghia, R.; Storlazzi, C.T.; Zito, A.;
et al. VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines 2023, 11, 2721.
https://doi.org/10.3390/biomedicines11102721
AMA Style
Schirizzi A, Arshadi A, Tolomeo D, Schirosi L, Valentini AM, De Leonardis G, Refolo MG, Donghia R, Storlazzi CT, Zito A,
et al. VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines. 2023; 11(10):2721.
https://doi.org/10.3390/biomedicines11102721
Chicago/Turabian Style
Schirizzi, Annalisa, Aram Arshadi, Doron Tolomeo, Laura Schirosi, Anna Maria Valentini, Giampiero De Leonardis, Maria Grazia Refolo, Rossella Donghia, Clelia Tiziana Storlazzi, Alfredo Zito,
and et al. 2023. "VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment" Biomedicines 11, no. 10: 2721.
https://doi.org/10.3390/biomedicines11102721
APA Style
Schirizzi, A., Arshadi, A., Tolomeo, D., Schirosi, L., Valentini, A. M., De Leonardis, G., Refolo, M. G., Donghia, R., Storlazzi, C. T., Zito, A., Ricci, A. D., Vallarelli, S., Ostuni, C., Bencivenga, M., De Manzoni, G., Messa, C., Armentano, R., Giannelli, G., Lotesoriere, C.,
& D’Alessandro, R.
(2023). VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines, 11(10), 2721.
https://doi.org/10.3390/biomedicines11102721
